August in Review: Top stories on Contemporary OBGYN®
Take a look back at our most popular stories from August 2022.
Women's Preventive Services Initiative releases guidance for preventing obesity in midlife
The Women’s Preventive Services Initiative (WPSI) has released a new clinical guideline outlining their recommendations for preventing obesity among women in midlife.
Vivjoa approved for recurrent vulvovaginal candidiasis
Oteseconazole is a treatment option for those living with a previously unmet medical need.
Essentials of vulvovaginal dermatology
Correct terms and education can help normalize the conversation for patients.
Maternal mortality before and during COVID pandemic
Maternal deaths in the United States rose by a staggering 33% after the onset of the COVID-19 pandemic in March 2020, which is a significantly higher percentage than the 22% overall excess death estimate linked to the pandemic, according to a research letter published in JAMA Network Open.
Cervical cancer screening guidelines for adolescents
Teenaged girls at average risk don’t need Papanicolaou tests, but some special populations do.
New ICD-10 codes to know before October
Changes for ICD-10 documentation codes that go into effect in October 2022.
Finding the best fit
Best practices on discussing birth control for adolescents.
How much money are you losing in unnecessary meetings?
Tips to avoid wasting time and optimize meetings you do need.
FDA approves Visby’s test for at-home STI identification
Published: March 28th 2025 | Updated: March 28th 2025The FDA has approved Visby Medical’s at-home sexually transmitted infection test, allowing women to screen for chlamydia, gonorrhea, and trichomoniasis without a prescription.
Read More
